Alankrita Taneja, MD
@TanejaMD
Followers
660
Following
5K
Media
61
Statuses
806
Hematologist at Jefferson Einstein Philadelphia Hospital specializing in the treatment of Multiple Myeloma Opinions are my own and retweets are not endorsements
Philadelphia, PA
Joined October 2017
This strategy will likely result in increased step-up administration of bispecific antibodies in the community setting
ashpublications.org
Key Points. Without compromising efficacy, a single dose of prophylactic tocilizumab resulted in low rates of CRS (10.1%) and ICANS (5.9%).It decreases res
0
0
1
RT @RahulBanerjeeMD: Excellent - linvo approved for 🇺🇸 pts with myeloma!.👍🏻 Q2W & Q4W built into approval.👎🏻 FDA forced 4 prior lines agai….
0
4
0
RT @VincentRK: Just out! New IMS/ IMWG Definition of High Risk Myeloma. @JCO_ASCO #IMWG25. @Myeloma_Society @IMFmyeloma @NikhilMunshiMD @m….
0
117
0
My mentee, Chidi, an intern at @TJUHospital Einstein Philadelphia Hospital was awarded the Young Investigator Award at @SocietyofHemOnc for his work on Multiple Myeloma!! So excited for this rising star! 🌟🌟🌟💫.
0
1
18
RT @rajshekharucms: 'Less is more' maintenance therapy in #MultipleMyeloma!.Triplets→ASCT→3yr Len → D/C if MRD-neg (NGF+PET/CT-neg) .Result….
0
22
0
Had great thought provoking discussions at @LLSusa #myelomarounds #Philadelphia @TJUHospital with Dr Binder and 🌟 fellow Tara
0
0
7
RT @Myeloma_Doc: #Myeloma Paper of the Day: Study of outcomes in frail pts getting bispecifics finds best ORR 80% in frail vs 73% in non-fr….
0
10
0
RT @VincentRK: Here are my Top 5 #ASH24 @ASH_hematology myeloma abstracts. #ASH24VR . Links to the full abstract. My Top 5 are based on ne….
0
71
0
RT @Transplant_Doc: #ASH24 24-Hour Urine Testing Does Not Add Value to Multiple Myeloma Response Assessments: A Secondary Analysis of BMT C….
0
18
0
RT @Myeloma_Doc: #Myeloma Paper of the Day: Cool paper from @RahulBanerjeeMD showing analysis of S0777 and S1211 @SWOG trial data that lowe….
0
27
0
RT @OncData: In honor of #InternationalOverdoseAwareness Day, Alankrita Taneja and Matthew Hadfield sat down to discuss, raise #awareness,….
0
2
0
RT @OncData: On #WorldHumanitarianDay, we raise advocate for civilians around the world who are caught up in conflict and honor #humanitari….
0
1
0
RT @PSUMaryDom: Thrilled to be included in this amazing group of people. The blog I wrote in 2020 still very much resonates with me and wha….
0
2
0
RT @malaksalharbi1: This beautifully written piece describes exactly what, unfortunately, often happens in the clinic. Worth the read. @T….
connection.asco.org
In an original poem, Dr. Alankrita Taneja evokes a lesson learned from her patients on
0
1
0
Another CAR-T for Rr FL approved by FDA on May 15
oncdata.com
The FDA has granted accelerated approval to lisocabtagene maraleucel (Breyanzi®, Juno Therapeutics, Inc.) for adults with relapsed or refractory follicular
0
0
7
RT @xraytechdoc: Unfortunately, I did not match into orthopedics this year. I will be delaying graduation to reapply in #match2025. Open t….
0
53
0
Dr @JHillengass, the chief our MM division, opening the multiple myeloma presentations for the day @btfoundation @RoswellHemOnc
0
1
22
Dr @PallawiTorkaMD teaching us about geri heme at the @btfoundation Upstate NY Hematology and Hematology Oncology Conference
0
1
22